For Payers / Health Systems

Reduce avoidable cost in persistent pain

A small group of patients with persistent pain account for a disproportionate share of healthcare utilisation. These patients often move through multiple consultations, investigations, and treatments — without meaningful improvement.

This is not random. It reflects a predictable pattern of pathway mismatch.

See the numbers

The Cost Problem

Patients with persistent pain frequently follow a high-cost trajectory:

Repeated primary care and specialist consultations
Imaging and diagnostic investigations with low yield
Escalating pharmacological management
Ongoing functional impairment

Despite this, outcomes often remain unchanged.

Estimated cost per patient: $8,000–$15,000+

These costs accumulate without addressing the factors maintaining symptoms.

What Etiolinks Does

Etiolinks identifies patients at risk of ongoing escalation and supports early redirection. At the point of care, the system:

Identifies the drivers of symptom persistence
Flags pathway mismatch
Recommends targeted intervention aligned with mechanism
Highlights low-value or high-risk care pathways

System-Level Impact

Early identification and alignment enables:

Reduction in unnecessary imaging and investigation
Decreased repeat consultations and referrals
Lower reliance on medication escalation
More efficient allocation of care resources

Projected cost with early redirection: $1,500–$4,000 per patient

Where It Applies

Most impactful in:

Primary care settings
Value-based care models
High-utilisation patient groups
Chronic primary pain and related conditions

Why This Matters

Current systems respond to utilisation. Etiolinks addresses the cause of utilisation. By correcting pathway mismatch early, it is possible to:

Reduce avoidable spend
Improve patient outcomes
Contain downstream cost

Persistent pain is one of the most common drivers of avoidable healthcare cost.

It is also one of the least systematically addressed.

Request Access